Penumbra Inc

• Country

  United States of America

• Sector

  Health Care

• Industry group

  Health Care Equipment & Services

• Industry

  Health Care Equipment & Supplies

• Sub-sector

  Health Care

• Capitalization (millions of $)

  8416.1

• Ticker

  PEN.N

• ISIN

  US70975L1070

• IPO date

  2015-09-18

• Availability on Russian exchanges

  Yes

• Reporting for

  2024-02-22

• Date fact. publication of reports

  2023-12-31

Penumbra, Inc. is a global healthcare company. The Company is engaged in the design, development, manufacturing, and marketing of medical devices. It is focused on developing and building its portfolio of products, including its thrombectomy, embolization and access technologies. The Company's neuro products include Thrombectomy, Embolization, Neurovascular access, Neurosurgical Tools, and Virtual Reality Platform. Its Vascular products include Thrombectomy and Embolization. The principal specialist physicians and healthcare providers in its two target end markets include Neuro: Interventional neuroradiologists, neurosurgeons, interventional neurologists, occupational therapists, physical therapists, and physiatrists; Vascular: Interventional radiologists, vascular surgeons, and interventional cardiologists. The common vascular and neurovascular diseases the Company focuses on are Ischemic Stroke, Brain Aneurysm, Hemorrhagic Stroke, Venous Thromboembolism, and Acute Coronary Syndrome.